Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
HLN

Haleon plc

HLNLSEUnited KingdomHealthcareDrug Manufacturers - Specialty & GenericFTSE 100

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth…more

P/E18.87xP/B1.94xROIC7.1%Dividend yield1.9%
£31.58B
Market Cap
EV: £39.28B
MOM4
QUAL8
VAL5
RSK2
HLN
£31.58B
Market Cap · EV £39.28B

Haleon plc

MOM4
QUAL8
VAL5
RSK2

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth…more

Analyst consensus: Buy

As of 22 Jul 2026, 18 analysts rate Haleon plc a Buy, with 61% buy ratings and a mean price target of 414p (range 315p–512p), +12% vs the current price.

Strong buy: 3Buy: 8Hold: 5Sell: 1Strong sell: 1

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 274p against a current price of 366p (-25%), based on EV/EBITDA.

More Healthcare companies